Defining and describing benefit appropriately in clinical trials.
about
Clinical trials and medical care: defining the therapeutic misconceptionSham neurosurgery in patients with Parkinson's disease: is it morally acceptable?International variation in ethics committee requirements: comparisons across five Westernised nationsPlacebo in Surgical Research: A Case-Based Ethical Analysis and Practical ConsequencesIn plain sight: a solution to a fundamental challenge in human research.Empirical Data on Benefits Children Experience in Clinical Research.Recent developments in gene transfer: risk and ethics.'Like sugar and honey': the embedded ethics of a larval control project in The Gambia.What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011.Do U.S. regulations allow more than minor increase over minimal risk pediatric research? Should they?Cell-based interventions in utero: time to reconsiderTherapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.Stem cell trials for cardiovascular medicine: ethical rationale.Assessing the quality of informed consent in a resource-limited setting: a cross-sectional study.Involving children in non-therapeutic research: on the development argument.The ethics of HIV "cure" research: what can we learn from consent forms?The social value of clinical research."When they see us, it's like they have seen the benefits!": experiences of study benefits negotiations in community-based studies on the Kenyan Coast.What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent.Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysisRegulatory and ethical issues for phase I in utero gene transfer studies.Addressing risks to advance mental health research.Extending clinical equipoise to phase 1 trials involving patients: unresolved problems"It is not guaranteed that you will benefit": True but misleading?Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs.Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?Consent and assent to participate in research from people with dementia.Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.Ethical considerations in tissue engineering research: Case studies in translation.Are risks and benefits of oncological research protocols both incommensurable and incompensable?Empirical examination of the potential adverse psychological effects associated with pediatric FMRI scanning.The future of incidental findings: should they be viewed as benefits?Planning for Ancillary Care Provision: Lessons From the Developing World.Research involving pediatric stem cell donors: A way forward.For love and money: the need to rethink benefits in HIV cure studies.Interpretation of the subjects' condition requirement: a legal perspective.Protecting participants of clinical trials conducted in the intensive care unit.Justice, fairness, and membership in a class: conceptual confusions and moral puzzles in the regulation of human subjects research.Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients.
P2860
Q21144663-2E1A8583-CC05-484C-9AF5-1CE9754C4035Q24682435-6FEBAE1A-8024-49A6-A59C-B9987E12544CQ24807396-7D7C8E9A-89F3-4BB1-8326-52ECC70BD140Q28070138-1E387059-C13B-435B-B749-397C0F30D8AEQ30456370-A40E2EFF-21DF-459F-9A99-DB0672825479Q31024590-57BA9AF4-0605-4D2F-BE8F-E56F1D7C4A37Q33709989-020C8855-F630-4531-8AFF-C6F5E984E55EQ33882258-59302619-3BB9-49E0-9068-A1319233CC58Q33920607-8ECFD92E-29B2-4A32-8C5F-B93A1DDAF109Q34081839-C0993CD9-04BF-4F44-A62F-5268E4270127Q34198128-23BC825E-9C7B-4550-A770-F4EC13D53612Q34251038-D3E8AFD2-0351-4317-8108-C49187E0B5BCQ34331206-65CAF871-31F5-4805-BB06-40797B4C20F3Q34385745-F2E79294-EECE-439C-8B56-76795F5D6FADQ34729576-D3686372-2DCB-4D0F-99FB-B195C6D1044CQ34869484-B7644397-94A9-4713-B142-9590E66B5C80Q35238851-4E3DD4F2-2354-40B4-9848-D14B010B6204Q35336844-EC3450C6-45D7-406D-B81E-A5FD9872CD3CQ35359689-46AC60BD-54AE-4B0D-9BEB-2030D2940FE6Q35429376-20D90389-CBB8-4EBA-9858-C09A9B1DC8B9Q35575680-840C782E-3BDE-4BC6-B41D-584E374D8EE3Q35786243-AE28272D-DBE5-450D-84CC-E201B807C964Q35788038-2F5CCCCA-59ED-4E0C-8346-236591C5D3D9Q35862658-33C2FDEA-C579-41FB-8B1C-7B4A8434DD18Q36014074-88125ABE-E100-47C0-B7CE-C3D390D9FDDCQ36112980-711971A7-4FDC-4CBA-BD68-8FBAAEDE9C61Q36736782-CA8C5542-671D-4D70-8BE9-91D4B4DA46CAQ36749688-7D3927A3-FF70-49CB-B784-7361082A15AEQ36885357-57A68AD8-AA1C-482C-8139-93477F7AFC2AQ36908952-52D92B8E-9B12-4C53-BE86-EE67946B7BB3Q36944964-D0EC4E01-8CC7-4659-A942-9B84C2FD5A00Q36947686-83F0231E-6A71-43E6-8E4B-055717AB2D1FQ36980883-CD5D7C11-550A-4CE9-B89A-0457A4F6AA7BQ37029700-5B2C3B72-87C7-4963-A267-8F3509AF3FF0Q37136342-4070CBED-2B2D-4688-A4E9-15F22B3C736EQ37627228-1B9AA469-7CCE-4EB7-A238-938741856D74Q37767766-B45DEB7C-4299-4029-BA32-445AA558C87CQ37901975-0D995A82-B0DF-4F88-98D9-CD25D59BC5C3Q37922803-E583D30F-3CAC-45CC-AFAC-F5F8814026AEQ38069234-EB3C213B-19FA-4A0D-A4F5-D0CCD2C86E82
P2860
Defining and describing benefit appropriately in clinical trials.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Defining and describing benefit appropriately in clinical trials.
@ast
Defining and describing benefit appropriately in clinical trials.
@en
Defining and describing benefit appropriately in clinical trials.
@nl
type
label
Defining and describing benefit appropriately in clinical trials.
@ast
Defining and describing benefit appropriately in clinical trials.
@en
Defining and describing benefit appropriately in clinical trials.
@nl
prefLabel
Defining and describing benefit appropriately in clinical trials.
@ast
Defining and describing benefit appropriately in clinical trials.
@en
Defining and describing benefit appropriately in clinical trials.
@nl
P2860
P1476
Defining and describing benefit appropriately in clinical trials.
@en
P2093
P2860
P304
P356
10.1111/J.1748-720X.2000.TB00685.X
P577
2000-01-01T00:00:00Z